Utah Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 8 (62% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,347
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 48.78%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 215
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 54.19%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 43.80% 38.14%
White, Hispanic/Latino Patients 32.07% 33.95%
Black/African American, Non-Hispanic/Latino Patients 0.59% 0.00%
Black/African American, Hispanic/Latino Patients 0.00% 0.00%
Asian Patients3 0.59% 0.47%
American Indian/Alaska Native Patients3 0.45% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.37% 0.93%
Patients with More than one race3 2.82% 4.19%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.83% 5.58%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 9.35% 13.49%
Unreported/Refused to Report Race and Ethnicity 5.12% 3.26%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 370
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 71.35%
COVID-19 Immunization Series Completed 394
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 64.34%
COVID-19 Immunization Series Additional 21
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 23.53%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 26.49% 33.76% 61.90%
White, Hispanic/Latino Patients 45.95% 43.40% 9.52%
Black/African American, Non-Hispanic/Latino Patients 3.24% 1.02% 0.00%
Black/African American, Hispanic/Latino Patients 0.00% 0.00% 0.00%
Asian Patients3 1.35% 0.51% 0.00%
American Indian/Alaska Native Patients3 0.81% 0.51% 4.76%
Native Hawaiian/Other Pacific Islander Patients3 0.27% 0.25% 0.00%
Patients with More than one race3 8.11% 7.61% 4.76%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 6.22% 7.61% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.81% 1.78% 19.05%
Unreported/Refused to Report Race and Ethnicity 6.76% 3.55% 0.00%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 37.50%
1 to 24 Hours 25.00%
More Than 24 Hours 37.50%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 0.00%
Vaccine confidence 50.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 50.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 101.88%
Average Percent of Health Center Visits Conducted Virtually 8.12%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 25.00%
Number of Mobile Van Sites 9
Number of Pop-up Clinics 0
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 50.00%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 25.00%
Patient awareness/education 0.00%
Staffing capacity 12.50%
Therapy administration/onsite logistics 25.00%
Other 0.00%
None 50.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021